Medisse has completed its move to its new premises in Leusden, bringing the whole company to one location. The overall increase of space will be a key contributor to the company’s projected growth, and allows it manage all vital functions from one location, from development to clinical evaluation to the first product launch within the next 2 years. The new location offers greatly increased laboratory space, which allows for small scale production.
“Having the whole company at one location will greatly enhance our overall efficiency and prepares us for the expected growth in the next couple of years. I am very pleased to have our team united under one roof,” said Sandra de Vos, founder and CEO of Medisse.
Leusden is conveniently located in the centre of the Netherlands with excellent connections to the Dutch motorway system and public transport.